Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F.

J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.

2.

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.

Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M, Zambello R, Tarella C, Di Nicola M, D'Arco AM, Doa G, Bruno-Ventre M, Assanelli A, Foppoli M, Citterio G, Fanni A, Mulè A, Caligaris-Cappio F, Ciceri F.

J Clin Oncol. 2015 Nov 20;33(33):3903-10. doi: 10.1200/JCO.2015.61.1236. Epub 2015 Aug 17.

PMID:
26282634
3.

Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.

D'Arco AM, Califano C, Barone L, Belsito Petrizzi V, Iovino V, Langella M, Maglione V, Rivellini F, De Lorenzo S.

Br J Haematol. 2015 Nov;171(4):662-5. doi: 10.1111/bjh.13429. Epub 2015 Apr 14. No abstract available.

PMID:
25873239
4.

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.

Conte M, Dell'Aversana C, Benedetti R, Petraglia F, Carissimo A, Petrizzi VB, D'Arco AM, Abbondanza C, Nebbioso A, Altucci L.

Oncotarget. 2015 Jan 20;6(2):886-901.

5.

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Merli M, Visco C, Spina M, Luminari S, Ferretti VV, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D'Arco AM, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L.

Haematologica. 2014 Mar;99(3):489-96. doi: 10.3324/haematol.2013.094318. Epub 2013 Nov 22.

6.

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.

Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F, Spina M, Ferreri AJ, Zinzani PL, Gallamini A, Mastronardi S, Boccomini C, Gaidano G, D'Arco AM, Di Raimondo F, Carella AM, Santoro A, Musto P, Federico M.

Ann Oncol. 2013 Aug;24(8):2108-12. doi: 10.1093/annonc/mdt137. Epub 2013 Apr 12.

PMID:
23585513
7.

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program.

Maurillo L, Venditti A, Spagnoli A, Gaidano G, Ferrero D, Oliva E, Lunghi M, D'Arco AM, Levis A, Pastore D, Di Renzo N, Santagostino A, Pavone V, Buccisano F, Musto P.

Cancer. 2012 Feb 15;118(4):1014-22. doi: 10.1002/cncr.26354. Epub 2011 Jul 14.

8.

Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.

D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N.

Eur J Haematol. 2007 Jul;79(1):53-8. Epub 2007 May 28.

PMID:
17532766
9.

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.

Pignata S, Scambia G, Savarese A, Breda E, Scollo P, De Vivo R, Rossi E, Gebbia V, Natale D, Del Gaizo F, Naglieri E, Ferro A, Musso P, D'Arco AM, Sorio R, Pisano C, Di Maio M, Signoriello G, Annunziata A, Perrone F; MITO Investigators.

BMC Cancer. 2006 Aug 1;6:202.

10.

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.

D'Arena G, Laurenti L, Capalbo S, D'Arco AM, De Filippi R, Marcacci G, Di Renzo N, Storti S, Califano C, Vigliotti ML, Tarnani M, Ferrara F, Pinto A.

Am J Hematol. 2006 Aug;81(8):598-602.

11.

An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients.

Palmieri S, D'Arco AM, Celentano M, Mele G, Califano C, Pollio F, D'Amico MR, Ferrara F.

Ann Oncol. 2006 Jul;17(7):1146-51. Epub 2006 May 10.

PMID:
16687417
12.

Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.

Ferrara F, D'Arco AM, De Simone M, Mele G, Califano C, Pocali B, Danise P, Palmieri S.

Haematologica. 2005 Jun;90(6):776-84.

13.

[Homozygous hemoglobin-E (Hb-EE) disease].

Amendola G, Danise P, Di Palma A, Franzese M, Avino D, D'Arco AM.

Pediatr Med Chir. 2004 Jan-Feb;26(1):65-7. Italian.

PMID:
15529816
14.

Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.

Ferrara F, Palmieri S, Annunziata M, Viola A, Pocali B, Califano C, D'Arco AM, Mele G.

Bone Marrow Transplant. 2004 Oct;34(7):573-6.

PMID:
15258559
15.

Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.

Risitano AM, Camera A, Chiurazzi F, Rossi M, D'Arco AM, Rotoli B.

Haematologica. 2002 Aug;87(8):ELT36. No abstract available.

PMID:
12161381
16.

[Clinical evaluation of the use of a chronopluricorticoid in the therapy of active chronic hepatitis].

Mauro R, Calatola P, D'Arco AM, Lettieri A, Maiorino A, Santoro A.

Clin Ter. 1979 Oct 15;91(1):19-40. Italian. No abstract available.

PMID:
397870

Supplemental Content

Loading ...
Support Center